Indoramin API is a pharmaceutical-grade alpha-1 adrenergic receptor blocker used primarily in the treatment of hypertension (high blood pressure) and benign prostatic hyperplasia (BPH). It blocks postsynaptic alpha-1 adrenergic receptors, producing peripheral vasodilation, reducing vascular resistance, and improving urinary flow by relaxing smooth muscle in the prostate and bladder neck.
Indoramin is formulated into oral tablet formulations and has been used in cardiovascular and urological therapies where alpha-adrenergic blockade is clinically beneficial.
Manufactured under WHO-GMP-certified facilities, our Indoramin API is produced using advanced pharmaceutical manufacturing processes to ensure exceptional purity, stability, and batch-to-batch consistency. Every batch undergoes rigorous quality testing and is supplied with complete documentation, including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), Technical Data Sheet (TDS), and Product Specifications.
Indoramin API is used in oral pharmaceutical formulations for the treatment of hypertension and benign prostatic hyperplasia (BPH).
Indoramin blocks alpha-1 adrenergic receptors, relaxing blood vessels to reduce blood pressure and relaxing smooth muscles in the prostate and bladder neck to improve urinary flow.
Yes. We provide CoA, MSDS, Technical Data Sheet (TDS), Product Specifications, and complete regulatory documentation with every shipment.
Yes. We supply Indoramin API in commercial quantities with worldwide export support and customized packaging.
Get Bulk Quote via WhatsApp